Align Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow ALGN
Align Technology, Inc. (ALGN) P/S ratio
As of 16 October 2026, Align Technology, Inc. (ALGN) trades at a P/S ratio of 2.5×. Over the past ten years it has ranged from 2.3× (September 2025) to 19.8× (February 2021); the current reading is higher than 3% of that period. That is in line with the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.4×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 2.8× | (28.09%) |
| FY2024 | 3.9× | (26.63%) |
| FY2023 | 5.3× | 19.73% |
| FY2022 | 4.4× | (66.13%) |
| FY2021 | 13.1× | (22.94%) |
| FY2020 | 17.0× | 84.90% |
| FY2019 | 9.2× | 7.99% |
| FY2018 | 8.5× | (30.16%) |
| FY2017 | 12.2× | 70.28% |
| FY2016 | 7.2× | 15.08% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 2.9× | (2.56%) |
| Mar 2026 | 3.0× | 6.49% |
| Dec 2025 | 2.8× | 23.37% |
| Sep 2025 | 2.3× | (34.33%) |
| 42 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BLCO Bausch + Lomb Corporation compare | 1.1× |
| BAX Baxter International Inc. compare | 1.1× |
| AVTR Avantor, Inc. compare | 1.7× |
| SOLV Solventum Corporation compare | 1.8× |
| ATR AptarGroup, Inc. compare | 2.0× |
| TFX Teleflex Incorporated compare | 2.5× |
| ALGN Align Technology, Inc. | 2.5× |
| COO The Cooper Companies, Inc. compare | 2.6× |
| RGEN Repligen Corporation compare | 12.6× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.4× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on ALGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement